A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Clinical trial NCT03811652 · COMPLETED

Trial details

NCT number: NCT03811652
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Metastatic Castration-resistant Prostate Cancer (mCRPC)

Start date: 2018-12-20
Primary completion: 2019-12-10
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.